Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stanke-Labesque

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
La Revue De Medecine Interne|April 14, 2000
[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects]J L Cracowski, F Stanke-Labesque, G Bessard
Clinical Pharmacology and Therapeutics|February 10, 2017
Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be GenotypedE Gautier-Veyret, X Fonrose, F Stanke-Labesque
Therapie|August 21, 2002
[Leukotrienes and 12-HETE: key mediators of angiotensin II-mediated vascular effects.Rol in hypertension]F Stanke-Labesque, G Hardy, J L Cracowski, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Isoprostanes: new markers of oxidative stress in human diseases]J L Cracowski, F Stanke-Labesque, C Souvignet, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassayJ Bessard, J L Cracowski, F Stanke-Labesque, et al.
Fundamental & Clinical Pharmacology|February 19, 2000
Are isoprostanes a clinical marker for antioxidant drug investigation?C Souvignet, J L Cracowski, F Stanke-Labesque, et al.
Therapie|June 22, 2000
[In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]F Stanke-Labesque, J L Cracowski, P Devillier, et al.
Journal of Vascular Research|April 24, 2001
Vascular biology of the isoprostanesJ L Cracowski, P Devillier, T Durand, et al.
Fundamental & Clinical Pharmacology|July 7, 1999
Functional assessment of rat aorta after cold storage in different mediaF Stanke-Labesque, J L Cracowski, P Devillier, et al.
Diabetologia|June 11, 2010
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetesR Boizel, G Bruttmann, P Y Benhamou, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
La Revue De Medecine Interne|April 14, 2000
[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects]J L Cracowski, F Stanke-Labesque, G Bessard
Clinical Pharmacology and Therapeutics|February 10, 2017
Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be GenotypedE Gautier-Veyret, X Fonrose, F Stanke-Labesque
Therapie|August 21, 2002
[Leukotrienes and 12-HETE: key mediators of angiotensin II-mediated vascular effects.Rol in hypertension]F Stanke-Labesque, G Hardy, J L Cracowski, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Isoprostanes: new markers of oxidative stress in human diseases]J L Cracowski, F Stanke-Labesque, C Souvignet, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassayJ Bessard, J L Cracowski, F Stanke-Labesque, et al.
Fundamental & Clinical Pharmacology|February 19, 2000
Are isoprostanes a clinical marker for antioxidant drug investigation?C Souvignet, J L Cracowski, F Stanke-Labesque, et al.
Therapie|June 22, 2000
[In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]F Stanke-Labesque, J L Cracowski, P Devillier, et al.
Journal of Vascular Research|April 24, 2001
Vascular biology of the isoprostanesJ L Cracowski, P Devillier, T Durand, et al.
Fundamental & Clinical Pharmacology|July 7, 1999
Functional assessment of rat aorta after cold storage in different mediaF Stanke-Labesque, J L Cracowski, P Devillier, et al.
Diabetologia|June 11, 2010
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetesR Boizel, G Bruttmann, P Y Benhamou, et al.
Pageof 4